troglitazone has been researched along with Choroid Neovascularization in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " PPAR-gamma ligands significantly inhibited VEGF-induced migration and proliferation in both cell types and tube formation of CEC in a dose-response manner." | 1.31 | Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. ( Hangai, M; He, S; Hinton, DR; Hsueh, WA; Ishibashi, T; Kim, S; Law, RE; Murata, T; Ryan, SJ; Xi, XP, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murata, T | 1 |
| He, S | 1 |
| Hangai, M | 1 |
| Ishibashi, T | 1 |
| Xi, XP | 1 |
| Kim, S | 1 |
| Hsueh, WA | 1 |
| Ryan, SJ | 1 |
| Law, RE | 1 |
| Hinton, DR | 1 |
1 other study available for troglitazone and Choroid Neovascularization
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
Topics: Animals; Blotting, Western; Cell Division; Cell Movement; Choroid; Choroidal Neovascularization; Chr | 2000 |